First-line treatment strategy for H. pylori infection is evolving

Eradication rate of traditional therapies has declined

Clarithromycin-based triple therapy
eradication rates declined from 90% to 72%
between 1996 and 20041

First-line treatment strategy for H. pylori infection is evolving

REFERENCES: 1. Shiota S, Reddy R, Alsarraj A, et al. Antibiotic resistance of Helicobacter pylori among male United States veterans. Clin Gastroenterol Hepatol. 2015;13:1616-1624. 2. Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report. Gut. 2012;61:646-664. 3. O’Connor A, Gisbert JP, O’Morain C, Ladas S. Treatment of Helicobacter pylori infection 2015. Helicobacter. 2015;20(Suppl 1):54-61. 4. Venerito M, Krieger T, Ecker T, Leandro G, Malfertheiner P. Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection. Digestion. 2013;88(1):33-45.